Prof. Anna Latos-Bieleńska: Molecular diagnostic needs are not fully met

- The needs for molecular diagnostics are very urgent and met only to a certain extent. We must divide patients who need targeted therapy and require molecular diagnostics into two groups. The first is oncology patients, who have reimbursed high-throughput genomic testing or next-generation sequencing panels. The situation is worse in rare diseases. In terms of diagnostics, they are still orphan diseases. I look forward and hope that this will change," said Prof. Anna Latos-Bieleńska, national consultant in clinical genetics, in an interview with Medexpress during the Economic Forum in Karpacz.